Form 4: Corbus Pharmaceuticals Holdings Executive Receives Stock Gra
Insider Transaction (Form 4)
Leonardo Viana Nicacio, Chief Medical Officer of Corbus Pharmaceuticals Holdings, Inc., reported multiple transactions in common stock on August 16, 2026.
Summary
- Grant/award: acquired 58,333 Common Stock, par value $0.0001 per share on August 16, 2026; holds 58,333 after (Direct).
- Grant/award: acquired 191,676 Stock options (right to buy) on August 16, 2026; holds 191,676 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Leonardo Viana Nicacio — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-16 | Grant/award | Common Stock, par value $0.0001 per share | 58,333 | — | — | 58,333 |
| 2026-08-16 | Grant/award | Stock options (right to buy) | 191,676 | — | — | 191,676 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-16 | Grant/award (58,333 shares) |
| 2026-08-16 | Grant/award (191,676 shares) |
Keywords
insider transaction, Form 4, CRBP, Corbus Pharmaceuticals Holdings, Inc., neutral, Leonardo Viana Nicacio
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.